Business Breakdowns

Iridex Corp (IRIX): Transforming Eye Care

You can listen/watch this conversation on Spotify, Apple Podcast, and YouTube.

By David Barbato · Mar 9, 2026 · 1 min read min read
Iridex Corp (IRIX): Transforming Eye Care

In this Business Breakdown, David Barbato and Christian Schmidt sit down with Iridex (IRIX) CEO Patrick Mercer and CFO Romeo Dizon. This discussion took place live on February 27th, 2026, on the MicroCapClub Community. Not part of the community? Join us.

Interact and learn with 250+ of the best microcap investors on the planet:

Join Us

This comprehensive interview with Patrick Mercer and Romeo Dizon of Iridex covers the company's strategic focus, financial turnaround, product portfolio, market opportunities, and future plans. Gain insights into how Iridex is positioning itself for growth in ophthalmic laser technology and the healthcare industry.

You can listen/watch this business breakdowns on SpotifyApple Podcast, and YouTube below:

Disclaimer: All content in this newsletter is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this newsletter and MicroCapClub.com. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and MicroCapClub.com are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed on MicroCapClub.com is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of publication and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information. FULL DISCLAIMER and TERMS OF USE

Free · No Spam · Unsubscribe Anytime

Get New Posts In Your Inbox

Educational articles and microcap insights from full-time investors.

Check your inbox to confirm your subscription. Please enter a valid email address.
Join 30,000+ investors · Free forever · Unsubscribe anytime
LATEST POSTS

Keep Reading MicroCap Insights

View All →